Scopus Atıf Havuzu

Clinical Strategies Against Early Hematoma Expansion Following Intracerebral Hemorrhage

Effect of the replacement of soybean meal with a processed protein meal mix on performance, carcass characteristics, blood parameters and cecum microbial population in broiler chickens

Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Emerging technologies for conversion of sustainable algal biomass into value-added products: A state-of-the-art review

Simple and effective removal of psychiatric pharmaceuticals from wastewater treatment plant effluents by magnetite red mud nanoparticles

One Hundred Years of Hybrid Necrosis: Hybrid Autoimmunity as a Window into the Mechanisms and Evolution of Plant-Pathogen Interactions

Prediction Accuracy Model Aiming to Improve Prediction Accuracy in Congenital Heart Anomaly Detection using Hybrid Feature Selection with Modified Particle Swarm Optimization Approach

Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments

Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients

Nanofertilizers as tools for plant nutrition and plant biostimulation under adverse environment

The early interferon catches the SARS-CoV-2

Correlations between body measures with live weight in young male goats

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19